2025
SJR Q1
JCR Q2 · 2,8
OA
2 matched articles
ESCI
Journal detail
Journal of Migration and Health
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
26666235
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,994
- Quartile Q1
- H-Index 27
- Cites/doc 3,27
- Docs (3y) 201
- Cites (3y) 702
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,8
- 5Y JIF 3,5
- JCI 0,78
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Demography Q1
- Health (social science) Q1
- Infectious Diseases Q1
- Sociology and Political Science Q1
Areas
- Medicine
- Social Sciences
WoS categories
- Public, Environmental & Occupational Health
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,994 | 2,8 | 3,5 | 0,78 | Q2 | 27 |
| 2024 | Q1 | Q2 | 1,529 | 2,9 | 3,7 | 1,01 | Q1 | 21 |
| 2023 | Q1 | Q1 | 1,515 | 3,9 | 4 | 0,94 | Q2 | 21 |
| 2022 | Q1 | — | 1,445 | 4,6 | 4,6 | 0,94 | Q2 | 21 |
| 2021 | — | — | — | — | — | — | — | 21 |
| 2020 | — | — | — | — | — | — | — | 21 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ESCI | Q2 | Q2 | 149/443 |
| 2024 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ESCI | Q2 | Q1 | 118/421 |
| 2023 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ESCI | Q1 | Q2 | 61/408 |
| 2022 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ESCI | — | Q2 | — |